Cabometyx (Cabozantinib)

Cabometyx is a medication containing cabozantinib, used for targeted therapy in certain cancers. It works by inhibiting tumor growth and angiogenesis, offering a treatment option for advanced conditions.

Cabometyx is primarily used in the treatment of advanced renal cell carcinoma and hepatocellular carcinoma. It targets specific proteins involved in tumor growth and blood vessel formation, helping to slow the progression of these cancers. Patients often wonder, 'What is Cabometyx used for?' It is designed for those who have limited treatment options due to advanced disease stages.

Common effects of Cabometyx may include fatigue, diarrhea, and high blood pressure. Some patients also experience nausea, vomiting, and changes in appetite. These effects can vary in severity and may require monitoring by a healthcare provider.

Cabometyx should be handled with care, following the prescribed dosage and administration guidelines. It is important to inform healthcare providers about any pre-existing conditions or other medications being taken to avoid potential complications. Regular check-ups may be necessary to monitor for side effects.

Cabometyx may interact with certain medications, including those that affect liver enzymes. Alcohol and other substances that impact liver function should be avoided. Patients should consult their healthcare provider before starting or stopping any medications while on Cabometyx.